|
rs1501299
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In summary, this meta-analysis indicated that adiponectin rs1501299G/T, rather than rs822395A/C and rs822396A/G polymorphism, was associated with risk of cancer development, especially for colorectal and prostate cancer.
|
23225349 |
2013 |
|
rs1501299
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We found that rs12733285, rs7539452, rs266729, rs822395, rs822396, and rs1501299 were significantly associated with prostate cancer risk.
|
21397927 |
2011 |
|
rs2241766
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In the meta-analysis, LEP rs7799039 (allele contrast: OR 1.133, 95%CI 1.024-1.254), ADIPOQ rs2241766 (allele contrast: OR 1.201, 95%CI 1.015-1.422) and ADIPOR1 rs10920531 (allele contrast: OR 1.184, 95%CI 1.075-1.305) variants were identified to be correlated with increased risk of prostate cancer.
|
27768592 |
2016 |
|
rs182052
|
|
|
0.010 |
GeneticVariation |
BEFREE |
ADIPOQ rs266729 and rs182052 were not related to PCa risk or plasma adiponectin levels.
|
25038177 |
2015 |
|
rs266729
|
|
|
0.010 |
GeneticVariation |
BEFREE |
ADIPOQ rs266729 and rs182052 were not related to PCa risk or plasma adiponectin levels.
|
25038177 |
2015 |
|
rs3774262
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A significant interaction between ADIPOQ rs3774262 and body mass index was observed in modifying the risk of PCa (P = 6.7 × 10⁻³).
|
25038177 |
2015 |
|
rs822395
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In summary, this meta-analysis indicated that adiponectin rs1501299G/T, rather than rs822395A/C and rs822396A/G polymorphism, was associated with risk of cancer development, especially for colorectal and prostate cancer.
|
23225349 |
2013 |
|
rs822396
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In summary, this meta-analysis indicated that adiponectin rs1501299G/T, rather than rs822395A/C and rs822396A/G polymorphism, was associated with risk of cancer development, especially for colorectal and prostate cancer.
|
23225349 |
2013 |
|
rs2082940
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among the 12 tagging polymorphisms in ADIPOQ, four (rs266729, rs182052, rs822391, and rs2082940) were significantly associated (P < 0.05) with overall prostate cancer risk, with no significant difference by tumor grade or clinical stage.
|
21960694 |
2011 |
|
rs822391
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among the 12 tagging polymorphisms in ADIPOQ, four (rs266729, rs182052, rs822391, and rs2082940) were significantly associated (P < 0.05) with overall prostate cancer risk, with no significant difference by tumor grade or clinical stage.
|
21960694 |
2011 |